Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.

Powell, Timothy R

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. [electronic resource] - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology Sep 2013 - 1105-14 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1873-7862

10.1016/j.euroneuro.2012.09.009 doi


Adult
Aged
Biomarkers--metabolism
Citalopram--administration & dosage
Cytokines--biosynthesis
Depressive Disorder--drug therapy
Drug Delivery Systems--methods
Female
Humans
Inflammation Mediators--metabolism
Male
Middle Aged
Pharmacogenetics--methods
Polymorphism, Single Nucleotide--genetics
Selective Serotonin Reuptake Inhibitors--administration & dosage
Transcriptome--physiology
Treatment Outcome
Tumor Necrosis Factor-alpha--biosynthesis
Young Adult